| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GLUCOSAMINE
ID: ALA606759
Max Phase: Preclinical
Molecular Formula: C6H13NO5
Molecular Weight: 179.17
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O
Standard InChI: InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6+/m1/s1
Standard InChI Key: MSWZFWKMSRAUBD-UKFBFLRUSA-N
Associated Targets(non-human)
Rattus norvegicus 775804 Activities
SARS-CoV-2 38078 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 179.17 | Molecular Weight (Monoisotopic): 179.0794 | AlogP: -3.25 | #Rotatable Bonds: 1 |
| Polar Surface Area: 116.17 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 11.73 | CX Basic pKa: 8.23 | CX LogP: -3.04 | CX LogD: -3.93 |
| Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.29 | Np Likeness Score: 2.14 |
References
| 1. Open TG-GATES, [10.6019/CHEMBL3885861] |
| 2. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
Source
Source(2):